(Q36938341)

17 August 2017

0 references

mFOLFOX6 Chemotherapy after Resection of Anal Canal Mucinous Adenocarcinoma (English)

1 reference

17 August 2017

Mototsugu Matsunaga

1

1 reference

17 August 2017

Keisuke Miwa

2

1 reference

17 August 2017

Yosuke Oka

3

1 reference

17 August 2017

Sachiko Nagasu

4

1 reference

17 August 2017

Takahiko Sakaue

5

1 reference

17 August 2017

Masaru Fukahori

6

1 reference

17 August 2017

Tomoyuki Ushijima

7

1 reference

17 August 2017

Yoshito Akagi

8

1 reference

17 August 2017

1 January 2016

1 reference

17 August 2017

Case reports in oncology

1 reference

17 August 2017

9

1 reference

17 August 2017

1

1 reference

17 August 2017

280-284

1 reference

Review on adjuvant chemotherapy for rectal cancer - why do treatment guidelines differ so much?

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4881242

29 September 2017

Cancer statistics, 2013

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4881242

Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4881242

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4881242

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4881242

Chemotherapy with preoperative radiotherapy in rectal cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4881242

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4881242

Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4881242

Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial

4 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27239184

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27239184

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Final results of randomized trials by the National Surgical Adjuvant Study of Colorectal Cancer (NSAS-CC)

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27239184

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1159/000446066

1 reference

17 August 2017

1 reference

17 August 2017

1 reference